Hui Peng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration (NCT07088445) | Hui Peng | 2025-09-01 |
Track Hui Peng automatically
Every clearance here is in the API, with alerts when new ones post.